Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With VerapamilSR/ Trandolapril Fixed Combination (Tarka) in Patients With Essential Hypertension in Routine Clinical Practice.

Trial Profile

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With VerapamilSR/ Trandolapril Fixed Combination (Tarka) in Patients With Essential Hypertension in Routine Clinical Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2012

At a glance

  • Drugs Verapamil/trandolapril (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 22 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 22 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top